Christopher Donnelly

Dr. Christopher Donnelly


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2015 in Nature
Verified
Journal Article
Closed access
PDF file
KZKe Zhang
Ke Zhang
CDChristopher Donnelly
Christopher Donnelly
AHAaron R. Haeusler
Aaron R. Haeusler
JGJonathan C. Grima
Jonathan C. Grima
JMJames B. Machamer
James B. Machamer
JRJeffrey D. Rothstein
Jeffrey D. Rothstein

5 March 2014 in Nature
Verified
Journal Article
Open access
PDF file
AHAaron R. Haeusler
Aaron R. Haeusler
CDChristopher Donnelly
Christopher Donnelly
GPGoran Periz
Goran Periz
ESEric A. J. Simko
Eric A. J. Simko
PSPatrick G. Shaw
Patrick G. Shaw
JWJiou Wang
Jiou Wang
A hexanucleotide repeat expansion (HRE), (GGGGCC)n, in C9orf72 is the most common genetic cause of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we identify a molecular mechanism by which structural polymorphism of the HRE leads to ALS/FTD pathology and defects. The HRE forms DNA and RNA G-quadruplexes with distinct structures and promotes RNA•DNA hybrids (R-loops). The structural polymorphism causes a repeat-length-dependent accumulation of transcripts aborted in the HRE region. These transcribed repeats bind to ribonucleoproteins in a conformation-dependent manner. Specifically, nucleolin, an essential nucleolar protein, preferentially binds the HRE G-quadruplex, and patient cells show evidence of nucleolar stress. Our results demonstrate that distinct C9orf72 HRE structural polymorphism at both DNA and RNA levels initiates molecular cascades leading to ALS/FTD pathologies, and provide the basis for a mechanistic model for repeat-associated neurodegenerative diseases.

1 October 2013 in Neuron
Verified
Journal Article
Closed access
CDChristopher Donnelly
Christopher Donnelly
PZPing-Wu Zhang
Ping-Wu Zhang
JPJacqueline T. Pham
Jacqueline T. Pham
AHAaron R. Haeusler
Aaron R. Haeusler
NMNipun A. Mistry
Nipun A. Mistry
JRJeffrey D. Rothstein
Jeffrey D. Rothstein

1 April 2019 in Neuron
Verified
Journal Article
Closed access
JMJacob R. Mann
Jacob R. Mann
AGAmanda M. Gleixner
Amanda M. Gleixner
JMJocelyn C. Mauna
Jocelyn C. Mauna
EGEdward Gomes
Edward Gomes
MDMichael R. DeChellis-Marks
Michael R. DeChellis-Marks
CDChristopher Donnelly
Christopher Donnelly

7 November 2010 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SLSonglin Li
Songlin Li
JOJustine J Overman
Justine J Overman
DKDiana Katsman
Diana Katsman
SKSerguei V Kozlov
Serguei V Kozlov
CDChristopher Donnelly
Christopher Donnelly
SCS Thomas Carmichael
S Thomas Carmichael
The authors compare the whole-genome expression profiles of peri-infarct neurons that show axonal sprouting after stroke to their non-sprouting neighbors. They describe a 'sprouting transcriptome' and perform further gain- and loss-of-function studies, finding novel roles in sprouting for a DNA-modifying molecule, a growth factor, and inhibitory myelin receptors. Stroke is an age-related disease. Recovery after stroke is associated with axonal sprouting in cortex adjacent to the infarct. The molecular program that induces a mature cortical neuron to sprout a new connection after stroke is not known. We selectively isolated neurons that sprout a new connection in cortex after stroke and compared their whole-genome expression profile to that of adjacent, non-sprouting neurons. This 'sprouting transcriptome' identified a neuronal growth program that consists of growth factor, cell adhesion, axonal guidance and cytoskeletal modifying molecules that differed by age and time point. Gain and loss of function in three distinct functional classes showed new roles for these proteins in epigenetic regulation of axonal sprouting, growth factor–dependent survival of neurons and, in the aged mouse, paradoxical upregulation of myelin and ephrin receptors in sprouting neurons. This neuronal growth program may provide new therapeutic targets and suggest mechanisms for age-related differences in functional recovery.

6 May 2016 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
AHAaron R. Haeusler
Aaron R. Haeusler
CDChristopher Donnelly
Christopher Donnelly
JRJeffrey D. Rothstein
Jeffrey D. Rothstein